Project Details
Description
A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic Adenocarcinoma TRYbeCA-1 - Trial of Eryaspase in pancreatic Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/18 → 10/30/22 |
Funding
- ERYTECH PHARMA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.